Nanotechnology-Enhanced Vaccines for Respiratory Infections: Opportunities and Challenges

Area of Science:

• Immunology
• Nanotechnology
• Vaccinology

Background:

• Global burden of respiratory infections persists despite existing vaccines.
• Conventional vaccines have limitations in inducing mucosal immunity and providing long-term protection against evolving pathogens.

Purpose of the Study:

• To review recent advancements in nanotechnology platforms for respiratory vaccines.
• To highlight the potential, opportunities, and challenges of nanotechnology-based respiratory vaccines.

Main Methods:

• Review of diverse nanotechnology platforms including lipid nanoparticles (LNPs), polymeric nanoparticles, inorganic nanoparticles, and biomimetic/self-assembling nanoplatforms.
• Analysis of how these platforms address limitations of traditional vaccines.

Main Results:

• Nanotechnology platforms enhance antigen stability and targeted delivery.
• These platforms improve mucosal and cellular immune responses and offer flexible formulations.
• Key limitations of traditional vaccines, such as poor mucosal immunity and short-term protection, can be addressed.

Conclusions:

• Nanotechnology presents promising solutions for next-generation respiratory vaccines.
• Challenges in safety, scalability, and real-world application are being addressed.
• Advancements in nanotechnological approaches offer new opportunities for preventing respiratory infections.